Research

Life Sciences & Biotechnology

Title :

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Chronic Diseases

Principal Investigator :

Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi

Timeline Start Year :

2017

Timeline End Year :

2022

Contact info :

Details

Total Budget (INR):

 10,00,000

Organizations involved

Implementing Agency :

All India Institute of Medical Sciences (AIIMS), New Delhi

Funding Agency :

Gilead Sciences, Inc., USA

Related Research

3'-UTR regulation of cardiac genes with roles in pressure overload cardiac hypertrophy
A combined approach of metabolomic, proteomic, transcriptomic and organization of photosynthetic apparatus from Chlamydomonas reinhardtiiunder various light intensities with different growth conditions
A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection
A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy
A study of KAP on blood donation among college students of different disciplines in Bhubaneswar, Odisha, Eastern India